BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Japan

Cell Therapies and Teijin Forge Strategic MoU to Build Asia-Pacific Cell and Gene Therapy Infrastructure

Cell Therapies Pty Ltd. (“Cell Therapies”) and Teijin Limited announced that they have signed a Memorandum of Unders...

October 02, 2025 | News

Japan Grants Orphan Drug Designation to JR-446 for Sanfilippo Syndrome Type B

MEDIPAL HOLDINGS CORPORATION and JCR Pharmaceuticals Co., Ltd. announced that the Ministry of Health, Labour and Welfare of Japa...

October 01, 2025 | News

Olympus Launches OLYSENSE™ AI Endoscopy Portfolio in US and Europe

Olympus Corporation (Olympus), a global MedTech company committed to making people’s lives healthier, safer and more fulfilling, today ann...

October 01, 2025 | News

Daiichi Sankyo and AstraZeneca’s ENHERTU delivers second positive phase 3 win in HER2 positive early breast cancer

Second positive phase 3 trial of Daiichi Sankyo and AstraZeneca’s ENHERTU in HER2 positive early breast cancer reinforces its potential to become...

September 30, 2025 | News

JCR Pharmaceuticals Achieves Milestone with Alexion in Neurodegenerative Disease Collaboration

-JCR Pharmaceuticals Co., Ltd., a global specialty biopharmaceutical company dedicated to developing therapies for rare and genetic diseases, has achieved ...

September 22, 2025 | News

Ono Pharmaceutical Wins EU Approval for Vimseltinib as First TGCT Therapy

Vimseltinib is the first and only therapy with marketing authorization for the treatment of TGCT in the European Union Ono Pharmaceutical Co., a...

September 19, 2025 | News

Japan Approves Novocure’s Optune Lua for Concurrent Use with PD-1/PD-L1 Inhibitors in Advanced NSCLC

Optune Lua is now approved for use concurrently with PD-1/PD-L1 inhibitors in adult patients with unresectable advanced/recurrent NSCLC who progressed on...

September 17, 2025 | News

Samsung Biologics Expands Presence in Japan with New Tokyo Office

Samsung Biologics has announced the opening of a new office in Tokyo, underscoring its long-term commitment to supporting Japan’s pharmaceutical and ...

September 09, 2025 | News

The State of Biotech and Life Science Jobs in Asia Pacific – 2025

In 2025, Asia-Pacific has emerged as the fastest-growing hub for biotech and life sciences employment, fuelled by a powerful combination of government supp...

September 09, 2025 | Report

Takeda Wins U.S. FDA Approval to Expand VONVENDI Use in Adults and Children with Von Willebrand Disease

Approval Expands Use of VONVENDI to Include Routine Prophylaxis to Reduce the Frequency of Bleeding Episodes in Adults with Type 1 and 2 Von Willebrand D...

September 08, 2025 | Regulatory

Celaid and AGC Partner in Japan to Advance Scalable Expansion of iPSC-Derived Blood Stem Cells

Celaid Therapeutics Inc. ("Celaid") have executed a collaborative research agreement with AGC Inc. ("AGC") to advance iPS cell-derived hematopoietic stem a...

August 29, 2025 | News

Cold Chain Technologies accelerates APAC expansion with new hubs, distributors, and manufacturing site

Cold Chain Technologies (CCT), has reinforced its commitment to expanding its Asia Pacific (APAC) presence with a series of investments and partnerships. ...

August 28, 2025 | News

Fujitsu Unveils Secure AI Agent Platform To Transform Healthcare Operations In Japan

Fujitsu announced the development of a secure and efficient AI agent platform to accelerate operational efficiency and ensure stable medical service provis...

August 28, 2025 | News

Otsuka Medical Devices Receives Japan Approval For Paradise Ultrasound Renal Denervation System To Treat Resistant Hypertension

Otsuka Medical Devices Co., Ltd. (“Otsuka Medical Devices”) announced that the Paradise™ Ultrasound Renal Denervation (uRDN) system has r...

August 26, 2025 | News

Stay Connected